Scholarly article on topic 'Neuropathology of brain and spinal malformations in a case of monosomy 1p36'

Neuropathology of brain and spinal malformations in a case of monosomy 1p36 Academic research paper on "Clinical medicine"

Share paper
Academic journal
Acta Neuropathologica Communications
OECD Field of science

Academic research paper on topic "Neuropathology of brain and spinal malformations in a case of monosomy 1p36"




Neuropathology of brain and spinal malformations in a case of monosomy 1p36

Naoko Shiba1, Ray AM Daza1, Lisa G Shaffer2, A James Barkovich3, William B Dobyns1,4 and Robert F Hevner1,5*


Monosomy 1p36 is the most common subtelomeric chromosomal deletion linked to mental retardation and seizures. Neuroimaging studies suggest that monosomy 1p36 is associated with brain malformations including polymicrogyria and nodular heterotopia, but the histopathology of these lesions is unknown. Here we present postmortem neuropathological findings from a 10 year-old girl with monosomy 1p36, who died of respiratory complications. The findings included micrencephaly, periventricular nodular heterotopia in occipitotemporal lobes, cortical dysgenesis resembling polymicrogyria in dorsolateral frontal lobes, hippocampal malrotation, callosal hypoplasia, superiorly rotated cerebellum with small vermis, and lumbosacral hydromyelia. The abnormal cortex exhibited "festooned" (undulating) supragranular layers, but no significant fusion of the molecular layer. Deletion mapping demonstrated single copy loss of a contiguous 1p36 terminal region encompassing many important neurodevelopmental genes, among them four HES genes implicated in regulating neural stem cell differentiation, and TP73, a monoallelically expressed gene. Our results suggest that brain and spinal malformations in monosomy 1p36 may be more extensive than previously recognized, and may depend on the parental origin of deleted genes. More broadly, our results suggest that specific genetic disorders may cause distinct forms of cortical dysgenesis.

Keywords: Periventricular nodular heterotopia, Hippocampal malrotation, Cortical dysgenesis, Malformations of cortical development, Hydromyelia, Mental retardation, Epilepsy


Monosomy 1p36 is the most common subtelomeric chromosomal deletion syndrome, with an estimated incidence of 1/5000-1/10000 births [1]. Of the ~95% of deletions that arise de novo, 60% affect the maternally derived chromosome [1], and manifest as various kinds of chromosomal rearrangements (e.g., interstitial deletions, derivative chromosomes, and more complex rearrangements, as well as pure terminal deletions). The clinical phenotype of monosomy 1p36 includes mental retardation, developmental delay, muscular hypotonia, speech delay, epilepsy, behavioral disorders (including panic, aggressiveness, and self-injury), sensorineural hearing loss, eye/vision problems, congenital heart defects, cardiomyopathy, gastrointestinal problems, precocious puberty, hyperphagia/ obesity, and dysmorphic features (deep-set eyes, flat nasal

* Correspondence:

1Seattle Children's Research Institute, 1900 Ninth Ave., Box C9S-10, Seattle, WA 98101, USA

5Department of NeurologicalSurgery, University of Washington, Seattle, WA, USA

Fulllist of author information is available at the end of the article

Bio Med Central

bridge, pointed chin, large and late-closing anterior fonta-nel, and clinodactyly) [1-5]. Mental retardation and developmental delay are seen in nearly 100% of patients, and are usually moderate or severe [5,6]. Generalized hypotonia is observed in >90% of patients, and epilepsy in 50-80% [4,6].

The chromosome deletion in most cases maps to the distal 10.5 Mb of 1p36, although the size varies and there is no common break point [1]. There is little correlation between the deletion size and the number of clinical features; even relatively small deletions (<3 Mb) can present with most of the typical phenotypic features [3,7]. Indeed, it has been suggested that some features of monosomy 1p36 might result from positional effects rather than a simple contiguous gene deletion [8]. On the other hand, the severity of neurological deficits including epilepsy, mental retardation and sensorineural hearing loss, as well as congenital heart diseases, has been suggested to correlate with the deletion size [6,8]. Furthermore, some specific phenotypes in the monosomy 1p36 syndrome — including polymicrogyria (PMG), hyperphagia/obesity, mental retardation, seizures, hearing loss, and periventricular nodular

© 2013 Shiba et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.Org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

heterotopia (PNH) — have been linked to critical regions within 1p36, each of which nevertheless contains multiple genes [2,4,9-11].

Although neuropsychiatric abnormalities are pivotal phenotypes in monosomy 1p36, their pathogenesis remains poorly understood. In most cases, neuroimaging reveals only mild or nonspecific changes such as microcephaly, ventriculomegaly, cerebral atrophy, abnormal patchy signal in white matter, and delayed myelination. Recently, however, evidence has accumulated that some fraction of monosomy 1p36 cases are affected with significant developmental brain malformations, including PMG, PNH, hypoplasia or agenesis of the corpus callosum, holoprosencephaly, cerebellar hypoplasia, and choroid plexus hyperplasia [10,12-19]. In one series, for example, 13 of 64 (20.3%) patients with monosomy 1p36 showed neuroimaging evidence of PMG [10].

In the present case report, we present the first neuro-pathological analysis of brain and spinal cord malformations in monosomy 1p36, from postmortem examination of a girl who died at 10 years of age. Our findings reveal new details of the malformations, and suggest that PMG in these patients represents a distinct form of cortical dysgenesis.

Case presentation

Clinical history

The subject was delivered at 39 weeks of gestation by caesarean section for breech position, to a 22 year-old, gravida 2, para 1 (1 spontaneous abortion) mother who had received special education in school. The father was a nonconsanguineous 37 year-old man with no known medical problems or significant family history. Birth weight was 2035 g (-3.7 SD). Apgar scores were 7 at 1 minute and 8 at 5 minutes. Neonatal cardiac evaluation showed a patent ductus arteriosus (PDA) and small ventricular septal defect (VSD). The PDA was ligated at age 7 weeks and the VSD closed spontaneously. She had severe conjugated hyperbilirubinemia transiently during early infancy, along with other findings suggestive of possible Alagille syndrome (posterior embryotoxon and butterfly vertebrae). However, liver biopsy showed no paucity of bile ducts (as present in Alagille syndrome) nor any other disease specific finding. Postnatal growth retardation (height < 5th centile), microcephaly (head circumstance < 5th centile), feeding difficulties, muscular hypotonia, and delayed motor and mental development were also noted. Infantile apneic spells were noted, prompting magnetic resonance imaging (MRI) that revealed cervicomedullary compression at the skull base; this was surgically decompressed. At 8 months of age, the patient was referred to the Department of Medical Genetics and was noted to exhibit dysmorphic features including bilateral low set small malformed ears, prominent forehead, deep set eyes, flat nasal bridge, pointed chin, short neck, and bilateral single transverse creases.

At age 13 months, growth hormone deficiency of unknown etiology was diagnosed and treated with growth hormone replacement therapy. The patient had severe gastro-esophageal reflux causing recurrent aspiration pneumonia; Nissen fundoplication with gastrostomy was done at 15 months of age. Precocious secondary sexual characteristics and clitoromegaly were noted at 22 months. The first apparent generalized tonic-clonic seizure occurred at age 5 years; seizures progressed, and were ultimately treated with combination anti-epileptic drug therapy. On serial neurological examinations, the patient never spoke any words nor walked, and her development remained profoundly delayed. She also had myopia with astigmatism and sensorineural hearing loss bilaterally. Self-injurious behavior (arm chewing) and teeth grinding were observed.

G-band karyotyping of peripheral blood lymphocytes showed a terminal deletion of chromosome 1p, read as 46,XX,del(1)(p36.31). The deletion in this region was confirmed by fluorescence in situ hybridization (FISH) using a subtelomeric DNA probe specific for the region, 1p36.3 (D1Z2; Oncor, Inc., cat #p5000-DG). The mother's karyo-type was normal; the father's karyotype was not available.

MRI examinations of the brain at several ages disclosed bilateral ventriculomegaly (Figure 1A-D). No progression of ventriculomegaly was noted upon repeated brain MRI. Electroencephalogram recordings showed slow background activity and frequent high amplitude multifocal discharges from the bilateral occipital lobes, compatible with focal epilepsy.

The patient died at age 10 years from cardiorespiratory failure.

General autopsy findings

A complete autopsy was performed with familial consent. The postmortem interval was 23.5 hours. The lungs showed patchy severe pneumonia, with postmortem lung cultures positive for Pseudomonas aeruginosa. The heart showed dysplasia of atrioventricular valves, but no cardiomyopathy. No hepatic or renal abnormalities were present.

Materials and methods

Neuropathological analysis

The brain was removed within 48 hours after death and was fixed for two weeks in 10% formalin. Representative samples of formalin-fixed brain and spinal cord were embedded in paraffin, sectioned at 6 ^m, and mounted on glass slides. Hematoxylin and eosin (H-E), Luxol fast blue (LFB), and cresyl violet (Nissl) stains utilized standard protocols. Age-matched normal human brain specimens were studied as controls.

Single-label immunoperoxidase staining was done using standard procedures. Double-label immunofluorescence was done as described [20]. The following primary antibodies were used: rabbit polyclonal antibodies against

Figure 1 MRI images at ages 1 and 10 years. (A) Sagittal T2 weighted image at age 1 year showed a smallcerebellar vermis (black arrows) and abnormalposterior arch of C1 (white arrow) causing compression of the posterior aspect of the upper cervical spinalcord. (B) Parasagittal T1 weighted image at age 10 years showed subtle irregularity of the cortical-white matter junction and the surface of the cortex in the left frontal lobe (arrows), consistent with polymicrogyria or similar dysgenesis. (C) CoronalT2 weighted image at age 10 years showed ventriculomegaly and malrotated hippocampi. (D) CoronalT2 weighted image at age 10 years at the levelof the ventricular trigones showed periventricular nodular heterotopia of moderate (black arrow) and small(white arrow) sizes.

glial fibrillary acidic protein (GFAP; DAKO, 1:2000); mouse monoclonal antibodies against neurofilament heavy chain (clone N52; Chemicon, Temecula, CA; diluted 1:300); microtubule-associated protein 1B (MAP1B; Chemicon; 1:400), microtubule-associated protein 2 (MAP2; Chemicon; 1:500), synaptophysin (Chemicon; 1:400), rabbit poly-clonal antibodies against calretinin (CR; Swant, Bellinzona, Switzerland; 1:2000). Primary antibody specificity was verified in control cortex. As a control for nonspecific binding of secondary antibodies, primary antibodies were omitted from some incubations.

Brightfield and fluorescence images were acquired using a Carl Zeiss Axio Imager Z1 microscope equipped with motorized stage and MosaiX software (Zeiss, USA). Images were photographed digitally and processed using Photoshop (Adobe, San Jose, CA, USA) to optimize brightness, contrast, and resolution. To map the positions of cells associated with deep and superficial cortical layers, N52+ cells and CR + cells (respectively) were plotted using different color dots (N52+ cells green, CR + cells red) against a black background, as described [21].

High-resolution chromosomal deletion mapping

Chromosomal deletions and duplications were analyzed using a bacterial artificial chromosome (BAC)-based micro-array (SignatureChip v3.0, Signature Genomic Laboratories, Spokane, WA) as described previously [22].


Neuropathological findings Macroscopic observations

The brain was small for age, weighing 858 g after formalin fixation, much less than expected (1290 g). The most prominent external brain abnormality was the "Moroccan leather"-like appearance of gyri in the dorsolateral frontal lobes bilaterally (Figure 2A-C). The gyral surface abnormalities, while most severe in the posterior portions of middle and superior frontal gyri, were not sharply delimited, but extended into adjacent cortical regions with gradually decreasing severity. Coronal slices of the hemispheres revealed bilateral ventriculomegaly, thin corpus callosum, focal cortical thickening especially in frontal lobes, and overall paucity of white matter (Figure 2D, E). Measurements of (non-polymicrogyric) cortex at several sulcal fundi showed the thickness ranged from 4.5 -7.6 mm, whereas normal cortex has a thickness of 3-4 mm [23]. Multiple periventricular heterotopias were identified, exhibiting both thin laminar and discrete nodular morphologies, scattered in the walls of the ventricular atria as well as occipital and temporal horns bilaterally (Figure 2E, E'). The macroscopic PNH measured ~0.3—1.0 cm in greatest dimension. The hippocampi were malrotated bilaterally (see below). The cerebellum exhibited a displaced, small, and anteriorly rotated vermis with normal organization of lobules (Figure 2F-H). The central canal of the lower thoracic and upper lumbar cord was mildly dilated (hydromyelia) (Figure 2I).

Histopathology of PMG-like cortical dysgenesis

Routine histological stains (H-E, LFB, Nissl) demonstrated six-layered cortex with possible "festooning" of the supragranular layers, but little or no significant fusion of the molecular layer. Rather, the molecular layer appeared to have variable thickness and irregular contours. To further analyze the PMG-like cortex, we used immunohistochemistry to study layer-specific antigens [24], including: N52 (neurofilament heavy chains, phos-phorylated and non-phosphorylated), labeling pyramidal neurons in layers 5 and 3; MAP1B, labeling deep more intensely than in superficial layers; and CR, labeling in-terneurons in layers 2-3 [24]. These studies revealed additional details of festooning and variable thickness in supragranular layers (Figure 3A-K). First, it was clear that macroscopic PMG-like bumps on the cortical surface (Figure 2C) correlated with thickening or convex undulations of the supragranular layers, while tiny sulci

Figure 2 Macroscopic neuropathology. (A) Superior aspect of brain showed "Moroccan leather" appearance of frontalcortex bilaterally. (B) Inferior aspect of brain showed smooth gyralsurfaces. (C) Surface of right frontalcortex corresponding to boxed area in (A), with leptomeninges removed, showed irregular surface of corticalgyri. (D) Coronalslice through the hemispheres revealed bilateralpolymicrogyria-like corticaldysgenesis (arrows) involving superior and middle frontalgyri. The gray-white matter junction was irregular in these regions. The corpus callosum was thin, and the lateraland third ventricles were enlarged. (E) Coronalslices of the left occipitallobe demonstrated multiple periventricular nodular heterotopia (arrows). (E') Magnified view of boxed area in E with multiple heterotopia (arrows). (F-H) The cerebellum exhibited a small, anteriorly rotated vermis with normalnumber of lobules. (I) Centralcanalof the lower thoracic and upper lumbar cord was mildly dilated. Scale bars: (in A) A, B, 3 cm; C, 1 cm; D, 3 cm; E, 2 cm; E', 1 cm; (in F) F, G, 3 cm; H, 2 cm; I, 0.5 cm.

correlated with supragranular thinning or concave undulations. Furthermore, the immunostains revealed that PMG-like cortical dysgenesis was more widespread than appreciated from abnormal surface morphology. For example, foci of supragranular festooning were evident not only in dorsolateral regions, but also in medial frontal and cingulate cortex, especially at the depths of sulci (Figure 3A, B). Nevertheless, the relative positions of supragranular and infragranular layers were preserved, as revealed by double labeling to detect CR (layers 2-3) and N52 (layers 5 and 3) in the same sections (Figure 3H-K). The cerebral white matter was atrophic, gliotic, and hypomyelinated (not shown).

Histopathology of periventricular heterotopia

The neuronal identity of PNH and adjacent thin laminar heterotopia along the walls of the occipital and temporal horns was confirmed by immunohistochemistry to detect

synaptophysin (Figure 3L). In addition, many numerous smaller nodular or linear heterotopia (<3 mm), often aligned along the interface between the subventricular zone and white matter, were synaptophysin immunoreactive (Figure 3L). These findings indicated that heterotopia, like regions of cortical dysgenesis, were more extensive than appreciated from macroscopic examination. Also, the PNH contained multiple neuron types, including N52+ pyramidal neurons as well as CR + interneurons (Figure 3M). Interestingly, in some PNHs, N52+ neurons were located predominantly in the center of the nodule, and CR + inter-neurons around the outside (Figure 3M, nodule at right). This observation suggests that some nodules may have had a rudimentary laminar structure.

Histopathology of the brainstem, cerebellum, and spinal cord The inferior olivary nuclei appeared mildly hypoconvoluted (Figure 3N). The cerebellar cortex exhibited patchy loss of

Figure 3 Histologic neuropathology. (A, B) Polymicrogyria-like corticaldysgenesis stained by immunohistochemistry for (A) N52 and (B) MAP1B. Note "festooned" supragranular layers in the patient's superior frontalgyrus (SFG) and adjacent dorsolateralfrontalcortex (superior up, lateralleft). The cingulate cortex (Cg) was unaffected, except in the depth of the cingulate sulcus. The corpus callosum (CC) was hypoplastic. (C-E) Lamination of normal, age-matched controlcortex demonstrated by (C) N52, (D) MAP1B, and (E) cresylviolet (Nissl) stains. (F, G) Polymicrogyria -like corticaldysgenesis seen at higher magnification (boxed areas from A, B). (H-K) Two-color, double-labelimmunofluorescence detection of N52 (green) and calretinin (red) in control(H, J) and patient (I, K) cerebralcortex. Low magnification views (H, I) show dot plots of immunolabeled cells. In patient cortex, the number and size of N52+ neurons appeared smaller, but the relative positions of N52+ and calretinin + neurons were unaltered. (L) Multiple synaptophysin-immunoreactive periventricular nodular heterotopia and smallirregular heterotopia were identified in occipitotemporalregions adjacent to the lateralventricle (LV). (M) Periventricular heterotopia exhibited N52 (green) and calretinin (red) immunoreactivity, represented in dot plots. Insets (a, b) show higher magnification photomicrographs. (N) The inferior olivary nuclei appeared slightly simplified with reduced convolutions. (O) The centralcanalof the spinalcord showed mild hydromyelia with a cross-shaped dilatation in lower thoracic and upper lumbar levels. Note also pallor of anterior and lateralfuniculi. Scale bars: (in A) A, B, 5 mm; (in C) C-E, 1 mm; (in F) F, G, 1 mm; (in H) H, I, 500 jm; (in J) J, K, 250 jm; L, 2 mm; M, 500 jm; N, 2 mm; O, 2 mm.

Purkinje neurons; the dentate nuclei were unremarkable. Histopathology of the hippocampus

The spinal central canal was moderately dilated at lower The bilateral hippocampi were malrotated through 90 thoracic and upper lumbar levels (Figure 3O). degrees as viewed in a coronal plane (Figure 4). Major


Figure 4 Hippocampal malrotation. (A, C) Normalcontrolhippocampus (stained with Luxolfast blue, and hematoxylin and eosin) and interpretive line diagram. (B, D) Patient hippocampus (immunostained to detect MAP2) and diagram. (B') Higher magnification of patient's dentate gyrus showing reduced neuronal population. The patient's hippocampus, including dentate gyrus (D), CA1-CA3, and subiculum (S) was rotated by ~90 degrees from normalorientation. The temporalhorn (T) of the lateralventricle directly contacted the subiculum in patient but not controlbrain. The entorhinalcortex (EC), characterized by large neuron clusters in supragranular layers, appeared expanded in the patient brain (smallarrows in D). Other abbreviations: P, presubiculum; L, lateralgeniculate nucleus; PNH, periventricular nodular heterotopia; TEC, transentorhinalcortex. Large arrows indicate collateralsulcus. Scale bars: (in B) A-D, 750 |jm; B', 75 |jm.

components of the archicortex (dentate gyrus, CA fields, and subiculum) were normally differentiated, but were oriented vertically rather than horizontally as in a normal control brain (Figure 4). The patient's subiculum was not attached to subjacent white matter, but instead was in direct contact with the expanded lateral ventricle, suggesting persistence of the fetal ventricular anatomy (Figure 4B, D). This configuration contrasted with the normal age-matched control hippocampus, in which the subiculum contacts subjacent white matter contiguous to the entorhinal cortex (Figure 4A, C). The entire hippocampus was also atrophic and gliotic, with marked neuronal loss in all regions, including the dentate gyrus (Figure 4B'). Interestingly, the entorhinal cortex appeared possibly expanded, and the choroid plexus appeared relatively large (Figure 4B), although no systematic chor-oid plexus hyperplasia was noted on MRI or macroscopic brain examination.

Chromosomal deletion mapping and affected genes

To gain further insights into the pathogenesis of brain and spinal malformations, we wished to map the chromosomal deletion with better resolution than provided by the clinical

karyotype. Microarray analysis using 969 BAC clones covering 304 genetic loci on 41 chromosome arms disclosed single copy loss of DNA from 34 BAC clones, covering a contiguous segment of 1p36 from Rp11-54O7 to RP1-126A5 (Figure 5). This deletion included approximately 6.8 Mb of distal chromosome 1p, within the typical range of deletion sizes for this syndrome [1,3]. The deleted segment contains 112 known or predicted genes, including CAMTA1, which is located within the identified breakpoint region and may have been partially deleted (Figure 5, and Additional file 1) [25]. Many of the deleted genes have previously been implicated in nervous system development by studies in humans and mice (Table 1). For example, Hes genes are known to be critical for brain and spinal growth in mice [26,27], and four HES genes (HES2, HES3, HES4, HES5) were deleted in the present case. The potential roles of deleted genes in causing brain and spinal malformations in monosomy 1p36 will be discussed further below.


The current monosomy 1p36 case, with a 6.8 Mb subtelomeric deletion, presented with conspicuous neuro-psychiatric abnormalities and other typical clinical

Figure 5 Terminal deletion in the distal short arm of chromosome 1. Microarray analysis showed a single-copy loss of 34 BAC clones from 1p36.3, spanning approximately 6.8 Mb, with break point between RP1-126A5 and RP3-438 L4. Probes are arranged with the most distalp-arm clones on the left. The blue tracing shows array comparative genomic hybridization data from the first microarray slide (reference Cy5/patient Cy3). The pink tracing shows data from the second microarray slide in which the dyes have been reversed (patient Cy5/reference Cy3). A subset of genes involved in neural development or function are indicated at their approximate position in the deleted region.

manifestations of this syndrome [3,12]. The patient also had some disorders that are not typically associated with monosomy 1p36, namely transient conjugated hyperbilirubinemia in early infancy, and growth hormone deficiency. Postmortem neuropathological examination revealed significant brain and spinal malformations, including: (1) occipitotemporal PNHs; (2) bifrontal cortical dysgenesis resembling PMG; (3) callosal hypoplasia; (4) hippocampal malrotation; (5) small, anteriorly rotated vermis; (6) simplified inferior olives; and (7) hydromyelia in the lower thoracic and upper lumbar spinal cord. However, the hydromyelia was mild, and may have been secondary to cervicomedullary compression. None of the malformations were detected during life, and the last four have not previously been reported in monosomy 1p36. Thus, our findings suggest that brain and spinal malformations in monosomy 1p36 may have been underestimated in previous studies. The present study may help to raise awareness and increase detection of these malformations in monosomy 1p36 [51].

Polymicrogyria-like cortical dysgenesis in monosomy 1p36

PMG is a poorly understood malformation characterized by excessive small gyri (often lending the cortex an irregular "Moroccan leather" surface appearance) and fusion of the molecular layer [52]. The first report of "possible polymicrogyria" in monosomy 1p36 was published in 1999

[14]. The presumed PMG in that case involved the left hemisphere, but no brain imaging or neuropathology was shown. More recently, it was reported that 13 of 64 (20%) monosomy 1p36 patients showed MRI evidence of PMG [10]. Interestingly, the apparent PMG affected perisylvian cortex preferentially, and involved the right hemisphere more often than the left. Also, the smallest deletion in that series was the last 4.8 Mb of 1p36, implying a critical region between BAC RP5-1096P7 and the 1p telomere. Subsequent studies have reported perisylvian PMG in three additional monosomy 1p36 patients [13,18,19]. Pachygyria and "coarse and nodular" cortex have also been described by neuroimag-ing in monosomy 1p36 [12]. However, none of the previous reports have documented the macroscopic brain pathology, or the histopathology of PMG in monosomy 1p36. Thus, the accuracy of the PMG diagnosis in monosomy 1p36, and its relation to other forms of PMG (not associated with monosomy 1p36), have remained uncertain.

Neuropathologists have distinguished several histological types of PMG on the basis of laminar morphology, but the significance of these variations is uncertain. The most common types of PMG have been described as "unlayered" and "four-layered"; less frequently, "two-layered" and "six-layered" PMG have been described [52-54]. In the present case, the cortical dysgenesis most resembled "six-layered" PMG. However, different

Table 1 Genes related to development and function of nervous system within region of 1p36.21-1p36.33 deletion

Symbol Description Locus Site Mouse ortholog Human diseases Null mouse phenotype Other Refs.

KLHL17 kelch-like 17 (Drosophila) 1p36.33 885,830..890,958 Klhl17 postsynaptic membrane [28]

HES4 Hairy and enhancer of split 4 (Drosophila) 1p36.33 924,207..925,333* ** HES gene family [26,27]

AGRN Agrin 1p36.33 945,366..981,355 Agrn CMS (AR) reduced NMJ [29]

SCNN1D sodium channel, nonvoltage-gated 1, delta 1p36.33 1,207,439..1,217,272 ** highly expressed in pyramidalneurons [30]

DVL1 dishevelled, dsh homolog 1 (Drosophila) 1p36.33 1,260,521..1,274,358* Dvl1 SJS (AR), CMT2A (AR) abnormalsocialinteractions [31,32]

MXRA8 matrix-remodelling associated 8 1p36.33 1,277,934..1,283,778* Mxra8 glia limitans/BBB [33]

VWA1 von Willebrand factor A domain containing 1 1p36.33 1,360,772..1,366,009 Vwa1 peripheralnerve defects ECM protein [34]

MIB2 Mindbomb homolog 2 (Drosophila) 1p36.33 1,540,747..1,555,848 Mib2 exencephaly ubiquitin ligase for Notch ligands [35]

MMP23B matrix metallopeptidase 23B 1p36.33 1,557,423..1,559,893 Mmp23 cranialsuture closure*** [36]

GNB1 guanine nucleotide binding protein (G protein), beta polypeptide 1 1p36.33 1,716,725..1,822,526* Gnb1 micrencephaly, NTDs One of three beta subunits of G proteins [37]

GABRD GABA A receptor, delta 1p36.33 1,940,703..1,952,050 Gabrd epilepsy pro-epileptic [38]

SKI v-ski sarcoma viraloncogene homolog (avian) 1p36.33 2,149,994..2,229,316 Ski facial clefting*** exencephaly, facialclefting, peripheralnerve myelination defects, PHPV, microphthalmos [39,40]

PEX10 peroxisomalbiogenesis factor 10 1p36.32 2,326,101..2,333,870* Pex10 ALD (AR), ZS (AR) [41]

PLCH2 phospholipase C, eta 2 1p36.32 2,397,614..2,426,824 Plch2 Mentalretardation neuron-specific isozyme [42]

HES5 Hairy and enhancer of split 5 (Drosophila) 1p36.32 2,450,044..2,451,544* Hes5 premature neuronal differentiation synergistic with Hes1, Hes3 [26,27]

TPRG1L tumor protein p63 regulated 1-like 1p36.32 3,531,416..3,536,555 Tprg1l presynaptic protein [43]

TP73 tumor protein p73 1p36.32 3,558,989..3,639,716 Trp73 Hippocampal, neocorticaldefects apoptosis [44,45]

KCNAB2 potassium voltage-gated channel, shaker-related subfamily, beta member 2 1p36.31 6,008,967..6,083,110 Kcnab2 Defects of learning and memory [46]

CHD5 chromodomain helicase DNA binding protein 5 1p36.31 6,084,440..6,162,770* Chd5 brain development, tumor suppressor gene [47]

HES3 Hairy and enhancer of split 3 (Drosophila) 1p36.31 6,226,849..6,228,225 Hes3 premature differentiation with Hes1, Hes5 [26,27]

ACOT7 acyl-CoA thioesterase 7 1p36.31 6,246,919..6,376,413* Acot7 MTLE [48]

HES2 Hairy and enhancer of split 2 (Drosophila) 1p36.31 6,397,883..6,402,566* Hes2 expressed in developing nervous system [26,27]

ESPN Espin 1p36.31 6,407,435..6,443,591 Espn congenital hearing loss (AR, AD) jerker deafness actin bundling [49]

PLEKG5 pleckstrin homology domain containing, family G (with RhoGef domain) member 5 1p36.31 6,448,739..6,502,656* Plekhg lower motor neuron disease (AR) activates NF kappa B [50]

w t . A a ii

t t a a

i- — t 3

AD autosomal dominant, ALD adrenoleukodystrophy, AR autosomal recessive, BBB blood-brain barrier, CMS congenital myasthenic syndrome, CMT2Ac Charcot-Marie-Tooth disease type 2A, ECM extracellular matrix, GABA gamma-aminobutyric acid, MTLE mesial temporal lobe epilepsy, NMJ neuromuscular junction, NTD neural tube defect, PHPV persistent hyperplastic primary vitreous, SJS Schwartz-Jampel syndrome, ZS Zellweger

syndrome. * complement = minus strand, ** none known, *** putative causative gene.

PMG types may occur together in the same brain, and (despite their different morphologies) all seem to exhibit similar relative positions of layer-specific neurons [54]. Also, on neuroimaging, PMG may be difficult to distinguish from other MCDs, such as pachygyria and "cobblestone" malformations involving breaches in the pial surface of the brain, which can also occur together with PMG in the same brain [55]. Recently, it was proposed that fusion of the molecular layer is a defining feature of PMG [54]. By this criterion, cortical dysgen-esis in the present case did not qualify as PMG, since little to no fusion of the molecular layer could be discerned (Figure 3). On the other hand, this is the only case of monosomy 1p36 with histopathological studies reported so far, and it is possible that authentic PMG with definite molecular layer fusion might occur in other cases; dysgenesis in the present case might represent a mild form of PMG. Alternatively, monosomy 1p36 may exhibit a unique form of "PMG-like" cortical dysgenesis, always lacking fusion of the molecular layer. Similarly to classic PMG [54], cortical dysgenesis in the present case showed no overall change in the relative positions of layer-specific neuron types (Figure 3H-K).

Heterotopia in monosomy 1p36

Subcortical heterotopia are caused by defective cell migration from the fetal ventricular zone to the cortical plate, and can appear as scattered neurons, laminar bands, or PNH [52,56]. The first report of PNH in monosomy 1p36 appeared in 2006 [15]. In that case, multiple PNH were identified in the anterior portion of the left lateral ventricle. Subsequent reports have described multiple PNH bilaterally [9], and one PNH in the left lateral ventricle [18] of mono-somy 1p36 patients. In the present case, multiple PNH were found in the temporal and occipital horns bilaterally (Figure. 1, 2 and 3). Thus, so far, there appears to be no consistent pattern in the distribution of PNH in monosomy 1p36, in contrast to some other forms of PNH, such as classic bilateral PNH linked to the FLNA gene on chromosome Xq28 [52].

Interestingly, laminar-like patterns are sometimes observed in PNH. In the present case, infragranular neurons (N52+ large pyramids) were located at the center of a nodule, and supragranular neurons (CR+) at the periphery (Figure 3M). Previous studies of PNH have reported disparate findings. One group reported that PNH contained predominantly supragranular neuron types, with very few infragranular-type neurons [57]. Another group found that PNH contained infragranular neurons at the periphery of nodules, with likely supragranular neurons occupying the center of nodules [58]. Altogether, the available data suggest that PNH may have variable composition, and may perhaps differ according to the genetic or other etiology of the malformation.

Hippocampal malrotation in monosomy 1p36

Neuroimaging studies suggest that hippocampal malrotation occurs relatively frequently in association with other MCDs (22-56%), in seizure disorders (up to 43%), and possibly in otherwise healthy controls (0-10%) [59-64]. Furthermore, hippocampal malrotation is the most common abnormality of the hippocampus associated with febrile status epilepticus in children [64]. However, the overall significance of the aforementioned studies has been clouded by the use of different criteria to define hippocampal malrotation, and by a lack of correlations with histopathology to directly ascertain the direction and degree of malrotation, as well as any associated changes in the organization of hippocampal fields or subregions. In the present case, hippocampal malrotation (Figure 4) was associated with seizures. Furthermore, the morphology suggested an abnormal persistence of fetal configuration. During normal development, the ventricular surface of the subiculum comes into contact with the ventricular surface of the parahippocampal gyrus between 17-20 weeks of gestation [65], and these apposed surfaces fuse by the end of gestation [66] to form, in the mature brain, a solid core of white matter between the subiculum, entorhinal, and transentorhinal areas. Thus, the pathogenic mechanisms underlying hippocampal malrotation in this case may have included decreased hippocampal growth, increased intraventricular pressure, or defective fusion at the ventricular surfaces.

Deleted genes and possible links to brain malformations

Like other subchromosomal deletion syndromes, monosomy 1p36 exhibits considerable phenotypic heterogeneity that may be attributed to multiple variables such as deletion size, genetic background, and intrauterine environment. Notably, the PMG-like cortical dysgenesis in monosomy 1p36 shows incomplete penetrance (~33%) [10] and variable distribution in the cerebral hemispheres and lobes [10,12-14,18,19]. Likewise, PNH seems to be variable in monosomy 1p36 [9,15,18]. Whereas the 1p36 region contains many genes that have been implicated in brain development or function (Table 1), some phenotypes presumably result from a combination of gene deficiencies. For these reasons, at present, it is impossible to definitively identify which gene deletions cause brain and spinal malformations in monosomy 1p36. However, reasonable candidate genes can be proposed on the basis of their previously defined functions in neurodevelopment, especially where critical regions have been defined. The brain phenotypes that seem most likely to have a genetic basis in the present case are micrencephaly, PMG-like cortical dysgenesis, and PNH. (As discussed above, hippocampal malrotation may have been secondary to ventriculomegaly and decreased overall brain growth).

Micrencephaly is a common finding in monosomy 1p36, affecting ~61% of patients [3], and was severe in the present

case. Several important genes that regulate brain size, and neuronal and glial differentiation, were deleted in this patient: these included four HES genes (HES2, HES3, HES4, and HES5), and GNB1. HES (hairy and enhancer of split) genes are basic helix-loop-helix transcriptional repressors that mediate the highly conserved Notch signaling pathway, which, in the nervous system, controls cellular fate choices between neural stem cell (NSC) maintenance and differentiation of neurons and glia [26,27]. In mice, multiple Hes genes function in a redundant, gene dose-dependent manner to mediate canonical Notch signaling. Mice lacking multiple Hes genes or related effectors undergo accelerated embryonic neuronal differentiation causing a premature and transient excess of neurogenesis, followed by NSC depletion and premature cessation of neurogenesis [27,67]. GNB1 (guanine nucleotide binding protein [G protein], beta polypeptide 1) encodes a G protein в subunit, one of five Gp genes in the mouse and human genomes [37]. Gnb1 deficient mice die prematurely in the embryonic or neonatal period with neural tube closure defects and micrencephaly [37]. The concurrent loss of one GNB1 allele and four HES alleles has never been modeled in mice, but would presumably be likely to cause micrencephaly.

The penetrance of PMG-like cortical dysgenesis in monosomy 1p36 has been estimated at ~33%, and the phenotype appears to be linked to a putative critical region between 1.0 Mb and 4.8 Mb from the 1p telomere [10]. This critical region, which was entirely deleted in the present case, includes several genes that might contribute to the PMG-like phenotype. One such candidate is TP73 (tumor protein p73), which encodes a member of the p53 family of transcription factors. In mice, Trp73 (the TP73 ortholog) is required for brain development. Trp73-/- mice show congenital hydrocephalus, hip-pocampal dysgenesis, absence of the hippocampal sulcus (a folding defect), decreased expression of reelin and calretinin (markers of Cajal-Retzius neurons) in the cortical marginal zone and hippocampal molecular layer, frontal cortex hypoplasia, occipital cortex dyslamination, ventralized cortical patterning with expanded entorhinal-like cortex, increased cortical apoptosis, and probably aberrant connections [44,45]. Indeed, it was suggested [44] that "Extrapolation of the [Trp73-/-] mouse brain defect on the human brain would predict a substantial reduction of primary visual cortex and occipitotemporal association areas, a damage that, combined with the entorhinal malformation, would lead to severe cognitive disabilities and mental retardation." Some defects in Trp73-/- mice, such as the expanded entorhinal-like cortex, seemed to show parallels in the present case of monosomy 1p36 (Figures 3 and 4). However, PMG-like festooning of the supragranular layers was not observed in Trp73-/- mice. Interestingly, human TP73 is expressed monoallelically and is probably imprinted [68]. This fact raises the intriguing possibility

that monosomy 1p36 may be associated with either complete loss or complete preservation of TP73 expression, depending on whether the transcriptionally active parental allele was deleted. If TP73 is imprinted and deficiency of TP73 causes a brain malformation (e.g., entorhinal expansion, PMG-like dysgenesis, or PNH), then such phenotypes may be correlated with deletion of a specific parental allele in monosomy 1p36. On the other hand, TP73 allele switching has been documented in some circumstances [68], and might provide a mechanism to counteract the effects of deleting an active TP73 allele.

Another leading candidate gene in the putative critical region for PMG-like cortical dysgenesis is PEX10 (peroxisomal biogenesis factor 10), which encodes a peroxi-somal RING finger ubiquitin ligase required for peroxisome biogenesis [69]. Loss-of-function mutations in PEX10 are one cause of Zellweger syndrome [69,70], a severe neurological disorder characterized by brain findings of centrosylvian PMG, medial pachygyria, subcortical heterotopias, and simplified inferior olivary nuclei [41]. However, Zellweger syndrome is a recessive disorder, and deletion of one PEX10 allele would not account for brain malformations on its own. Nor was there any history of peroxisomal disorders in the patient's family.

Reports of PNH in monosomy 1p36 are too few to estimate prevalence or define a critical region, but cases so far suggest limited expressivity with relatively few, small PNH. Usually categorized as a cell migration disorder, PNH may arise from disruptions of cytoskeletal proteins, vesicle trafficking, impaired cell adhesion, ependymal defects, or damage to radial glia [52,57,71]. Among genes deleted in the present case, MXRA8 (matrix-remodelling associated 8) encodes an immunoglobulin superfamily cell adhesion molecule that, in adults, is localized to astrocyte endfeet that form the glia limitans and blood-brain barrier [33,72]. Although the developmental functions of MXRA8 are unknown (since no gene deletion studies have been reported so far), one could speculate that it regulates cell migration or radial glia morphology. Another speculative candidate for contributing to PNH in monosomy 1p36 is CHD5 (chromodomain helicase DNA binding protein 5), which encodes one component of a chromatin remodeling complex that is preferentially expressed in the nervous system [73]. In primary cultured rat neurons, shRNA-mediated knockdown of Chd5 caused downregulation of some neuronal genes (such as Fmr1, Dlx1, and Nefm) and upregulation of others (such as L1cam, Gabrd, and Ampd3) [47]. Some of these changes, such as the upregulation of L1cam (which encodes an immuno-globulin superfamily cell adhesion molecule), might hypothetically interfere with cell migration and cause heterotopia. However, the developmental functions of Chd5 have not been studied in knockout mice and currently remain unknown.

Many other genes deleted in the present case have been implicated in nervous system function and probably contribute to developmental delay, epilepsy, and related neuropsychiatric problems in monosomy 1p36 (Table 1; Additional file 1). However, genes that are expressed only in mature postmitotic neurons are less likely to be involved in the pathogenesis of malformations, and more likely to contribute to abnormalities of neuronal plasticity or function. Overall, in most cases of monosomy 1p36, neurological problems reflect perturbations of both developmental and mature brain functions.


Our findings provide the first neuropathological evidence that multiple malformations of brain and spinal development occur in monosomy 1p36. The unique morphology of PMG-like cortical dysgenesis in the present case suggests that this lesion, in which fusion of the molecular layer was not evident (Figure 3), differs from classic PMG, in which fusion of the molecular layer is a defining feature [54]. More generally, our findings suggest that some types of PMG may exhibit unique morphologic features associated with different genetic and non-genetic etiologies. Finally, our analysis of the deleted chromosome region in this patient allowed us to not only identify candidate genes for malformations, but also propose a novel mechanism of phenotypic diversity in monosomy 1p36, namely the possibility that, due to imprinting, the penetrance of TP73-dependent phenotypes may be linked to deletion of a specific parental allele.


Written informed consent was obtained from the patient's parents for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor-in chief of this journal.

Additional file

Additional file 1: Genes within region of 1p36.21-1p36.33 deletion and references to gene functions.


BAC: Bacterialartificialchromosome; CR: Calretinin; GFAP: Glial fibrillary acidic protein; MAP: Microtubule-associated protein; MRI: Magnetic resonance imaging; NSC: Neuralstem cell; PDA: Patent ductus arteriosus; PMG: Polymicrogyria; PNH: Periventricular nodular heterotopia; VSD: Ventricular septaldefect.

Competing interests

There are no competing interests in the report. Authors' contributions

NS, RAMD, WBD and RFH performed clinicaland pathologicalstudies and analysis. LGS carried out the genetic studies. AJB analyzed the MRIimages. NS and RFH drafted the manuscript. Allauthors read and approved the final manuscript.


We thank Dr. Gina Elsen, Dr. Gordana Juric-Sekhar, Christiane Ulness, and Jill

Rosenfeld for technicalassistance.

Author details

Seattle Children's Research Institute, 1900 Ninth Ave., Box C9S-10, Seattle,

WA 98101, USA. 2Signature Genomic Laboratories, Spokane, WA, USA.

3Department of Radiology, University of California, San Francisco, San

Francisco, CA, USA. 4Department of Pediatrics, University of Washington,

Seattle, WA, USA. 5Department of NeurologicalSurgery, University of

Washington, Seattle, WA, USA.

Received: 18 July 2013 Accepted: 18 July 2013

Published: 2 August 2013


1. Heilstedt HA, Ballif BC, Howard LA, Lewis RA, Stal S, Kashork CD, Bacino CA, Shapira SK, Shaffer LG: Physical map of 1p36, placement of breakpoints in monosomy 1p36, and clinical characterization of the syndrome.

Am J Hum Genet 2003, 72:1200-1212.

2. D'Angelo CS, Kohl I, Varela MC, de Castro CI, Kim CA, Bertola DR, Louren?o CM, Koiffmann CP: Extending the phenotype of monosomy 1p36 syndrome and mapping of a critical region for obesity and hyperphagia. Am J Med Genet A 2010, 152A:102-110.

3. Gajecka M, Mackay KL, Shaffer LG: Monosomy 1p36 deletion syndrome. Am J Med Genet C Semin Med Genet 2007,145C:346-356.

4. Rosenfeld JA, Crolla JA, Tomkins S, Bader P, Morrow B, Gorski J, Troxell R, Forster-Gibson C, Cilliers D, Hislop RG, Lamb A, Torchia B, Ballif BC, Shaffer LG: Refinement of causative genes in monosomy 1p36 through clinical and molecular cytogenetic characterization of small interstitial deletions. Am J Med Genet A 2010, 152A:1951 -1959.

5. Shapira SK, McCaskill C, Northrup H, Spikes AS, Elder FF, Sutton VR, Korenberg JR, Greenberg F, Shaffer LG: Chromosome 1p36 deletions: the clinical phenotype and molecular characterization of a common newly delineated syndrome. Am J Hum Genet 1997, 61:642-650.

6. Kurosawa K, Kawame H, Okamoto N, Ochiai Y, Akatsuka A, Kobayashi M, Shimohira M, Mizuno S, Wada K, Fukushima Y, Kawawaki H, Yamamoto T, Masuno M, Imaizumi K, Kuroki Y: Epilepsy and neurological findings in 11 individuals with 1p36 deletion syndrome. Brain Dev 2005, 27:378-382.

7. Buck A, du Souich C, Boerkoel CF: Minimal genotype-phenotype correlation for small deletions within distal 1p36. Am J Med Genet A 2011,155A:3164-3169.

8. Redon R, Rio M, Gregory SG, Cooper RA, Fiegler H, Sanlaville D, Banerjee R, Scott C, Carr P, Langford C, Cormier-Daire V, Munnich A, Carter NP, Colleaux L: Tiling path resolution mapping of constitutional 1p36 deletions by array-CGH: contiguous gene deletion or "deletion with positional effect" syndrome? J Med Genet 2005,42:166-171.

9. Descartes M, Mikhail FM, Franklin JC, McGrath TM, Bebin M: Monosomy1p36.3 and trisomy 19p13.3 in a child with periventricular nodular heterotopia. Pediatr Neurol 2011, 45:274-278.

10. Dobyns WB, Mirzaa G, Christian SL, Petras K, Roseberry J, Clark GD, Curry CJ, McDonald-McGinn D, Medne L, Zackai E, Parsons J, Zand DJ, Hisama FM, Walsh CA, Leventer RJ, Martin CL, Gajecka M, Shaffer LG: Consistent chromosome abnormalities identify novel polymicrogyria loci in 1p36.3,2p16.1-p23.1, 4q21.21-q22.1, 6q26-q27, and 21q2. Am J Med Genet A 2008, 146A:1637-1654.

11. Gajecka M, Saitta SC, Gentles AJ, Campbell L, Ciprero K, Geiger E, Catherwood A, Rosenfeld JA, Shaikh T, Shaffer LG: Recurrent interstitial 1p36 deletions: Evidence for germline mosaicism and complex rearrangement breakpoints. Am J Med Genet A 2010, 152A:3074-3083.

12. Battaglia A, Hoyme HE, Dallapiccola B, Zackai E, Hudgins L, McDonald-McGinn D, Bahi-Buisson N, Romano C, Williams CA, Brailey LL, Zuberi SM, Carey JC: Further delineation of deletion 1p36 syndrome in 60 patients: a recognizable phenotype and common cause of developmental delay and mental retardation. Pediatrics 2008,121:404-410.

13. Campeau PM, Ah Mew N, Cartier L, Mackay KL, Shaffer LG, Der Kaloustian VM, Thomas MA: Prenatal diagnosis of monosomy 1p36: a focus on brain abnormalities and a review of the literature. Am J Med Genet A 2008, 146A:3062-3069.

14. Faivre L, Morichon-Delvallez N, Viot G, Martinovic J, Pinson MP, Aubry JP, Raclin V, Edery P, Dumez Y, Munnich A, Vekemans M: Prenatal detection of a 1p36 deletion in a fetus with multiple malformations and a review of the literature. Prenat Diagn 1999, 19:49-53.

15. Neal J, Apse K, Sahin M, Walsh CA, Sheen VL: Deletion of chromosome 1p36 is associated with periventricular nodular heterotopia. Am J Med Genet A 2006, 140:1692-1695.

16. Puvabanditsin S, Garrow E, Patel N, D'Elia A, Zaafran A, Phattraprayoon N, Davis SE: Choroid plexus hyperplasia and monosomy 1p36: report of new findings. J Child Neurol 2008, 23:922-925.

17. Ribeiro Mdo C, Gama De Sousa S, Freitas MM, Carrilho I, Fernandes I: Bilateral perisylvian polymicrogyria and chromosome 1 anomaly. Pediatr Neurol 2007, 36:418-420.

18. Saito S, Kawamura R, Kosho T, Shimizu T, Aoyama K, Koike K, Wada T, Matsumoto N, Kato M, Wakui K, Fukushima Y: Bilateral perisylvian polymicrogyria, periventricular nodular heterotopia, and left ventricular noncompaction in a girl with 10.5-11.1 Mb terminal deletion of 1p36. Am J Med Genet A 2008, 146A:2891 -2897.

19. Saito Y, Kubota M, Kurosawa K, Ichihashi I, Kaneko Y, Hattori A, Komaki H, Nakagawa E, Sugai K, Sasaki M: Polymicrogyria and infantile spasms in a patient with 1p36 deletion syndrome. Brain Dev 2011, 33:437-441.

20. Englund C, Folkerth RD, Born D, Lacy JM, Hevner RF: Aberrant neuronal-glial differentiation in Taylor-type focal cortical dysplasia (type IIA/B).

Acta Neuropathol 2005,109:519-533.

21. Hevner RF, Daza RA, Englund C, Kohtz J, Fink A: Postnatal shifts of interneuron position in the neocortex of normal and reeler mice: evidence for inward radial migration. Neuroscience 2004, 124:605-618.

22. Bejjani BA, Saleki R, Ballif BC, Rorem EA, Sundin K, Theisen A, Kashork CD, Shaffer LG: Use of targeted array-based CGH for the clinical diagnosis of chromosomal imbalance: is less more? Am J Med Genet A 2005,134:259-267.

23. Barkovich AJ, Koch TK, Carrol CL: The spectrum of lissencephaly: report of ten patients analyzed by magnetic resonance imaging. Ann Neurol 1991, 30:139-146.

24. Hevner RF: Layer-specific markers as probes for neuron type identity in human neocortex and malformations of cortical development.

J Neuropathol Exp Neurol 2007, 66:101-109.

25. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D: The human genome browser at UCSC. Genome Res 2002,12:996-1006.

26. Kageyama R, Ohtsuka T, Kobayashi T: The Hes gene family: repressors and oscillators that orchestrate embryogenesis. Development 2007,134:1243-1251.

27. Kageyama R, Ohtsuka T, Kobayashi T: Roles of Hes genes in neural development. Dev Growth Differ 2008, 50(Suppl 1):S97-S103.

28. Chen Y, Derin R, Petralia RS, Li M: Actinfilin, a brain-specific actin-binding protein in postsynaptic density. J Biol Chem 2002, 277:30495-30501.

29. Huzé C, Bauché S, Richard P, Chevessier F, Goillot E, Gaudon K, Ben Ammar

A, Chaboud A, Grosjean I, Lecuyer HA, Bernard V, Rouche A, Alexandri N, Kuntzer T, Fardeau M, Fournier E, Brancaccio A, Rüegg MA, Koenig J, Eymard

B, Schaeffer L, Hantaí D: Identification of an agrin mutation that causes congenital myasthenia and affects synapse function. Am J Hum Genet 2009, 85:155-167.

30. GiraldezT, Afonso-Oramas D, Cruz-Muros I, Garcia-Marin V, Pagel P, González-Hernández T, Alvarez De La Rosa D: Cloning and functional expression of a new epithelial sodium channel delta subunit isoform differentially expressed in neurons of the human and monkey telencephalon. J Neurochem 2007, 102:1304-1315.

31. Ahmad-Annuar A, Ciani L, Simeonidis I, Herreros J, Fredj NB, Rosso SB, Hall A, Brickley S, Salinas PC: Signaling across the synapse: a role for Wnt and Dishevelled in presynaptic assembly and neurotransmitter release.

J Cell Biol 2006, 174:127-139.

32. Long JM, LaPorte P, Paylor R, Wynshaw-Boris A: Expanded characterization of the social interaction abnormalities in mice lacking Dvl1. Genes Brain Behav 2004, 3:51 -62.

33. Yonezawa T, Ohtsuka A, Yoshitaka T, Hirano S, Nomoto H, Yamamoto K, Ninomiya Y: Limitrin, a novel immunoglobulin superfamily protein localized to glia limitans formed by astrocyte endfeet. Glia 2003,44:190-204.

34. Allen JM, Zamurs L, Brachvogel B, Schlötzer-Schrehardt U, Hansen U, Lamandé SR, Rowley L, Fitzgerald J, Bateman JF: Mice lacking the extracellular matrix protein WARP develop normally but have compromised peripheral nerve structure and function. J Biol Chem 2009, 284:12020-12030.

35. Wu JI, Rajendra R, Barsi JC, Durfee L, Benito E, Gao G, Kuruvilla M, Hrdlicková R, Liss AS, Artzt K: Targeted disruption of Mib2 causes exencephaly with a variable penetrance. Genesis 2007, 45:722-727.

36. Gajecka M, Yu W, Ballif BC, Glotzbach CD, Bailey KA, Shaw CA, Kashork CD, Heilstedt HA, Ansel DA, Theisen A, Rice R, Rice DP, Shaffer LG: Delineation of mechanisms and regions of dosage imbalance in complex

rearrangements of 1p36 leads to a putative gene for regulation of cranial suture closure. Eur J Hum Genet 2005, 13:139-149.

37. Okae H, Iwakura Y: Neural tube defects and impaired neural progenitor cell proliferation in gbetal-deficient mice. Dev Dyn 2010, 239:1089-1101.

38. Dibbens LM, Feng HJ, Richards MC, Harkin LA, Hodgson BL, Scott D, Jenkins M, Petrou S, Sutherland GR, Scheffer IE, Berkovic SF, Macdonald RL, Mulley JC: GABRD encoding a protein for extra- or peri-synaptic GABAA receptors is a susceptibility locus for generalized epilepsies. Hum Mol Genet 2004, 13:1315-1319.

39. Atanasoski S, Notterpek L, Lee HY, Castagner F, Young P, Ehrengruber MU, Meijer D, Sommer L, Stavnezer E, Colmenares C, Suter U: The protooncogene Ski controls Schwann cell proliferation and myelination. Neuron 2004, 43:499-511.

40. Colmenares C, Heilstedt HA, Shaffer LG, Schwartz S, Berk M, Murray JC, Stavnezer E: Loss of the SKI proto-oncogene in individuals affected with 1p36 deletion syndrome is predicted by strain-dependent defects in Ski-/- mice. Nat Genet 2002, 30:106-109.

41. Powers JM, Moser HW: Peroxisomal disorders: genotype, phenotype, major neuropathologic lesions, and pathogenesis. Brain Pathol 1998, 8:101-120.

42. Lo Vasco VR: Role of phosphoinositide-specific phospholipase C q2 in isolated and syndromic mental retardation. Eur Neurol 2011, 65:264-269.

43. Kremer T, Kempf C, Wittenmayer N, Nawrotzki R, Kuner T, Kirsch J, Dresbach T: Mover is a novel vertebrate-specific presynaptic protein with differential distribution at subsets of CNS synapses. FEBS Lett 2007, 581:4727-4733.

44. Meyer G, Cabrera Socorro A, Perez Garcia CG, Martinez Millan L, Walker N, Caput D: Developmental roles of p73 in Cajal-Retzius cells and cortical patterning. J Neurosci 2004, 24:9878-9887.

45. Yang A, Walker N, Bronson R, Kaghad M, Oosterwegel M, Bonnin J, Vagner C, Bonnet H, Dikkes P, Sharpe A, McKeon F, Caput D: p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 2000, 404:99-103.

46. Perkowski JJ, Murphy GG: Deletion of the mouse homolog of KCNAB2, a gene linked to monosomy 1p36, results in associative memory impairments and amygdala hyperexcitability. J Neurosci 2011, 31:46-54.

47. Potts RC, Zhang P, Wurster AL, Precht P, Mughal MR, Wood WH 3rd, Zhang Y, Becker KG, Mattson MP, Pazin MJ: CHD5, a brain-specific paralog of Mi2 chromatin remodeling enzymes, regulates expression of neuronal genes. PLoSOne 2011, 6:e24515.

48. Yang JW, Czech T, Yamada J, Csaszar E, Baumgartner C, Slavc I, Lubec G: Aberrant cytosolic acyl-CoA thioester hydrolase in hippocampus of patients with mesial temporal lobe epilepsy. Amino Acids 2004,27:269-275.

49. Donaudy F, Zheng L, Ficarella R, Ballana E, Carella M, Melchionda S, Estivill X, Bartles JR, Gasparini P: Espin gene (ESPN) mutations associated with autosomal dominant hearing loss cause defects in microvillar elongation or organisation. J Med Genet 2006,43:157-161.

50. Maystadt I, Rezsohazy R, Barkats M, Duque S, Vannuffel P, Remacle S, Lambert B, Najimi M, Sokal E, Munnich A, Viollet L, Verellen-Dumoulin C: The nuclear factor kappaB-activator gene PLEKHG5 is mutated in a form of autosomal recessive lower motor neuron disease with childhood onset. Am J Hum Genet 2007, 81:67-76.

51. Guerrini R, Dobyns WB, Barkovich AJ: Abnormal development of the human cerebral cortex: genetics, functional consequences and treatment options. Trends Neurosci 2008, 31:154-162.

52. Aronica E, Becker AJ, Spreafico R: Malformations of cortical development. Brain Pathol 2012, 22:380-401.

53. Ferrer I: A Golgi analysis of unlayered polymicrogyria. Acta Neuropathol 1984, 65:69-76.

54. Judkins AR, Martinez D, Ferreira P, Dobyns WB, Golden JA: Polymicrogyria includes fusion of the molecular layer and decreased neuronal populations but normal cortical laminar organization. J Neuropathol Exp Neurol 2011, 70:438-443.

55. Bahi-Buisson N, Poirier K, Boddaert N, Fallet-Bianco C, Specchio N, Bertini E, Caglayan O, Lascelles K, Elie C, Rambaud J, Baulac M, An I, Dias P, Des Portes V, Moutard ML, Soufflet C, El Maleh M, Beldjord C, Villard L, Chelly J: GPR56-related bilateral frontoparietal polymicrogyria: further evidence for an overlap with the cobblestone complex. Brain 2010, 133:3194-3209.

56. Barkovich AJ, Kuzniecky RI, Jackson GD, Guerrini R, Dobyns WB: A developmental and genetic classification for malformations of cortical development. Neurology 2005, 65:1873-1887.

57. Ferland RJ, Batiz LF, Neal J, Lian G, Bundock E, Lu J, Hsiao YC, Diamond R, Mei D, Banham AH, Brown PJ, Vanderburg CR, Joseph J, Hecht JL, Folkerth

R, Guerrini R, Walsh CA, Rodriguez EM, Sheen VL: Disruption of neural progenitors along the ventricular and subventricular zones in periventricular heterotopia. Hum Mol Genet 2009, 18:497-516.

58. Garbelli R, Rossini L, Moroni RF, Watakabe A, Yamamori T, Tassi L, Bramerio M, Russo GL, Frassoni C, Spreafico R: Layer-specific genes reveal a rudimentary laminar pattern in human nodular heterotopia. Neurology 2009, 73:746-753.

59. Bernasconi N, Kinay D, Andermann F, Antel S, Bernasconi A: Analysis of shape and positioning of the hippocampal formation: an MRI study in patients with partial epilepsy and healthy controls. Brain 2005,128:2442-2452.

60. Donmez FY, Yildirim M, Erkek N, Demir Karacan C, Coskun M: Hippocampal abnormalities associated with various congenital malformations. Childs Nerv Syst 2009, 25:933-939.

61. Gamss RP, Slasky SE, Bello JA, Miller TS, Shinnar S: Prevalence of hippocampal malrotation in a population without seizures. AJNR Am J Neuroradiol 2009, 30:1571-1573.

62. Kuchukhidze G, Koppelstaetter F, Unterberger I, Dobesberger J, Walser G, Zamarian L, Haberlandt E, Maier H, Ortler M, Gotwald T, Gelpi E, Czech T, Feucht M, Bauer G, Delazer M, Felber S, Trinka E: Hippocampal abnormalities in malformations of cortical development: MRI study. Neurology 2010, 74:1575-1582.

63. Montenegro MA, Kinay D, Cendes F, Bernasconi A, Bernasconi N, Coan AC, Li LM, Guerreiro MM, Guerreiro CA, Lopes-Cendes I, Andermann E, Dubeau F, Andermann F: Patterns of hippocampal abnormalities in malformations of cortical development. J Neurol Neurosurg Psychiatry 2006, 77:367-371.

64. Shinnar S, Bello JA, Chan S, Hesdorffer DC, Lewis DV, Macfall J, Pellock JM, Nordli DR, Frank LM, Moshe SL, Gomes W, Shinnar RC, Sun S, FEBSTAT Study Team: MRI abnormalities following febrile status epilepticus in children: the FEBSTAT study. Neurology 2012, 79:871 -877.

65. Bayer SA, Altman J: The Human Brain During the Second Trimester. Boca Raton, FL: CRC Press; 2005.

66. Bayer SA, Altman J: The Human Brain During the Third Trimester. Boca Raton, FL: CRC Press; 2004.

67. Imayoshi I, Sakamoto M, Yamaguchi M, Mori K, Kageyama R: Essential roles of Notch signaling in maintenance of neural stem cells in developing and adult brains. J Neurosci 2010, 30:3489-3498.

68. Mai M, Qian C, Yokomizo A, Tindall DJ, Bostwick D, Polychronakos C, Smith DI, Liu W: Loss of imprinting and allele switching of p73 in renal cell carcinoma. Oncogene 1998,17:1739-1741.

69. Waterham HR, Ebberink MS: Genetics and molecular basis of human peroxisome biogenesis disorders. Biochim Biophys Acta 1822,2012:1430-1441.

70. Warren DS, Wolfe BD, Gould SJ: Phenotype-genotype relationships in PEX10-deficient peroxisome biogenesis disorder patients. Hum Mutat 2000, 15:509-521.

71. Santi MR, Golden JA: Periventricular heterotopia may result from radial glial fiber disruption. J Neuropathol Exp Neurol 2001, 60:856-862.

72. Jung YK, Jin JS, Jeong JH, Kim HN, Park NR, Choi JY: DICAM, a novel dual immunoglobulin domain containing cell adhesion molecule interacts with alphavbeta3 integrin. J Cell Physiol 2008, 216:603-614.

73. Thompson PM, Gotoh T, Kok M, White PS, Brodeur GM: CHD5, a new member of the chromodomain gene family, is preferentially expressed in the nervous system. Oncogene 2003, 22:1002-1011.


Cite this article as: Shiba et al.: Neuropathology of brain and spinal malformations in a case of monosomy 1p36. Acta Neuropathologica Communications 2013 1:45.

Submit your next manuscript to BioMed Central and take full advantage of:

• Convenient online submission

• Thorough peer review

• No space constraints or color figure charges

• Immediate publication on acceptance

• Inclusion in PubMed, CAS, Scopus and Google Scholar

• Research which is freely available for redistribution

Submit your manuscript at Tpntral >_ciiuai